Results 111 to 120 of about 23,943 (202)

Advances in emerging therapies 2008 [PDF]

, 2009
Higgins, P., Lees, K.R.
core   +1 more source

Non-invasive Coronary Functional Tests in Patients with Angina and Non-obstructive Coronary Artery Disease. [PDF]

Eur Cardiol
Cambise N, Marino AG, De Benedetto F, Cortigiani L, Lenci L, De Vita A, Tremamunno S, Lombardo A, Ciampi Q, Leone AM, Montone RA, Trani C, Burzotta F, Picano E, Lanza GA.   +14 more
europepmc   +1 more source

From Cardiac Stress to Organ Distress: Acute Hepatorenal Dysfunction after Dipyridamole Myocardial Perfusion Imaging. [PDF]

Acta Cardiol Sin
Kao YT, Shih YC, Wang SY, Wu YW.
europepmc   +1 more source

Extracellular Adenosine Contributes to the Hydrogen Peroxide-Induced Calcification of Cultured Tendon Cells. [PDF]

Curr Issues Mol Biol
Sakuma T, Mahasarakham CPN, Lin X, Yoshitake H, Nifuji A, Noda M, Ezura Y.   +6 more
europepmc   +1 more source

Effectiveness of Aspirin Plus Dipyridamole Versus Clopidogrel in Preventing Recurrent Ischemic Stroke: A Systematic Review. [PDF]

Cureus
Osayagbon AE, Olaniyi AO, Oyovwi J, Banerjee A, Lawal OP, Butt MA.   +5 more
europepmc   +1 more source

40 Hz flicker preconditioning protects nonarteritic anterior ischemic optic neuropathy via adenosine signaling. [PDF]

Commun Biol
Su L, Lu R, Huang L, Jia M, Liao J, Huang L, Wu Y, Shi T, He X, He Y, Sun Z, Chen JF, Gao Y.   +12 more
europepmc   +1 more source

Cilostazol increases collateral remodeling and reduces the severity of ischemic stroke. [PDF]

J Cereb Blood Flow Metab
Zhang H, Ding MC, Gong G, Faber JE.
europepmc   +1 more source

Integrating In Vitro BE Checker with In Silico Physiologically Based Biopharmaceutics Modeling to Predict the Pharmacokinetic Profiles of Oral Drug Products. [PDF]

Pharmaceutics
Niino T, Masada T, Takagi T, Kataoka M, Yoshida H, Yamashita S, Kambayashi A.   +6 more
europepmc   +1 more source

Circulating S100A8/A9 drives faster platelet COX-1 recovery via MRP4, impairing the duration of aspirin response. [PDF]

Blood Adv
Liani R, Simeone PG, Alfonsetti M, Lattanzio S, Ricci A, Frezza M, Ciotti S, Luongo M, Cipollone F, Pulcinelli F, Santilli F.   +10 more
europepmc   +1 more source

Design and rationale of the AIR-NET trial: a randomised, open-label, multifactorial, multicentre, adaptive platform trial using a range of repurposed anti-inflammatory treatments to improve outcomes in patients with bronchiectasis within the EMBARC clinical research network. [PDF]

ERJ Open Res
Long MB, New JM, Stobo J, Band M, McLaren-Neil F, Hull R, Gilmour A, Lind H, McIntosh E, Galloway R, Eke Z, Harris B, Singanayagam A, Shah A, Huang J, Wilkinson T, Loebinger MR, Haworth CS, Chotirmall SH, De Soyza A, Chalmers JD.   +20 more
europepmc   +1 more source